NeuBase Therapeutics NBSE
$ 0.38
-1.56%
Quarterly report 2023-Q3
added 11-09-2023
NeuBase Therapeutics EV/EBITDA Ratio 2011-2024 | NBSE
Annual EV/EBITDA Ratio NeuBase Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
0.592 | -7.26 | -1.25 | -1.02 | -0.644 | -3.51 | -3.35 | -16.8 | -28.6 | -20.4 | -21.3 |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
0.592 | -28.6 | -9.41 |